← Open Payments lookup

XIN RU: Open Payments

NPI 1952008906 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$552 in 22 payments from 6 companies in 2025. Trend: 2023 $329 · 2024 $425 · 2025 $552

Food & beverage: $552
CompanyPaymentsAmount
Novo Nordisk Inc13$328
Bayer Healthcare Pharmaceuticals Inc.4$95
Amgen Inc.2$41
Alnylam Pharmaceuticals Inc.1$32
Novartis Pharmaceuticals Corporation1$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$25

Products named: Wegovy, Kerendia, Repatha, AMVUTTRA, LEQVIO, Ozempic, JARDIANCE.

Industry payments across CA — which companies pay providers there.